Australian TGA approves additional indication for Telix's Illuccix® to include patient selection for PSMA-Targeted ...

Researchers at the Francis Crick Institute and Vividion Therapeutics have identified chemical compounds that can precisely ...

Biotech innovator NeuroScientific Biopharmaceuticals has received the green light from Australia’s drugs regulator to treat ...

An update from Neuroscientific Biopharmaceuticals Ltd. ( ($AU:NSB) ) is now available. NeuroScientific Biopharmaceuticals has received approval ...

The drug may slow the progression of Alzheimer’s disease, but it doesn’t improve the symptoms. It’s also incredibly expensive ...

Some international users of Flow Neuroscience's device have labelled the wearable tech as a game-changer in treating ...

Riek Machar charged over White Army raids Case renews fears of return to conflict Suspended VP and co-accused deny charges Sept 22 (Reuters) - The treason trial of South Sudan's suspended First Vice ...

Sept 19 (Reuters) - Billionaire Elon Musk’s brain-implant company Neuralink plans to launch a trial in October aimed at helping people with speech impairments translate their thoughts into text, the ...

Karin Cain, who dated James Craig as he poisoned his wife, unpacks his trial. Dr. Karin Cain met Dr. James Craig at a dental conference in Las Vegas in early 2023. 21 days after they parted, Craig’s ...

SAN FRANCISCO, Sept. 18, 2025 /PRNewswire/ -- AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a clinical-stage biotechnology company advancing targeted ...

National Cancer Institute will stop funding research consortium that includes Children’s Hospital Colorado. Research on brain tumors in children that has been supported by the federal government will ...

Aspirin can cut by more than half the risk that colon cancer will come back following initial treatment, a new clinical trial has found. Daily aspirin reduced by 55% the risk of cancer recurrence in ...